Logo for Sandoz Group AG

Sandoz Group Investor Relations Material

Latest events

Logo for Sandoz Group AG

Q1 2024

Sandoz Group
Logo for Sandoz Group

Q1 2024

7 May, 2024
Logo for Sandoz Group

H2 2023

13 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Sandoz Group AG

Access all reports
Sandoz Group AG is a swiss pharmaceutical company focusing on the development, manufacture, and marketing of generic pharmaceuticals and biosimilars.Sandoz operates in two primary segments: generics, which include drugs that are structurally equivalent to original drugs whose patents have expired, and biosimilars, which, unlike generics, are slightly different from other approved reference biologics but have no clinically significant differences. With a global footprint, Sandoz engages in the healthcare technology field by buying and selling intellectual property and other assets related to generics and biosimilar drugs, both domestically and internationally. The company is headquartered in Rotkreuz, Switzerland, and its shares are listed on the SIX Swiss Exchange.